Clinical Feasibility Consortium
The Clinical Feasibility Consortium is a ZS-sponsored initiative that aims to advance medical science through the identification, prioritization and resolution of clinical trial issues that most affect the biopharma industry. Our mission is to enhance and optimize the execution of trials through strategic and forward-thinking collaboration among feasibility leaders, faster than any organization operating alone could achieve.
WHAT WE DO
Challenges we solve
Investing in data analytics and technology
As decision-making continues to become more data-driven, feasibility teams must continue to strengthen their analytics techniques. Our consortium shares tips to leverage RWD using artificial intelligence and machine learning to generate insights.
Benchmarking organizational processes
There is value in having local, boots-on-the-ground teams, even in the era of big data. We explore how our feasibility teams continue to evolve and recruit the right talent, while balancing new data with institutional knowledge.
Building partnerships
As biopharma companies continue to grow, their feasibility teams must remain nimble. Our consortium discusses issues surrounding centralized governance, shared goals and visions, data sharing, sustainable improvement and more.
Cultivating patient-sponsor relationships
It is more important than ever to connect the head and the heart. This means always putting the concerns and benefits of the patient first. To achieve this, we aim to address patient-centric trial designs, effective engagement strategies and more.
client success
We are a democratic think tank, helping clinical operations executives perform research and advocacy to prepare their organizations and professions to take ownership and prove their leadership in a new data-driven world.
145+
Countries where our consortium member companies conduct trials
2-3
Projects completed every year
100%
Funded by ZS, so our members pay no membership dues to participate in our consortium
2 trillion
Combined market cap of our consortium member companies
